These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26689593)

  • 21. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
    Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.
    Wu J; Zhao S; Tang Q; Zheng F; Chen Y; Yang L; Yang X; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 Sep; 34(1):99. PubMed ID: 26362062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells.
    Chuang CW; Pan MR; Hou MF; Hung WC
    J Cell Physiol; 2013 Feb; 228(2):341-8. PubMed ID: 22718198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents.
    Kambe A; Iguchi G; Moon Y; Kamitani H; Watanabe T; Eling TE
    Biochim Biophys Acta; 2008 Jun; 1783(6):1211-9. PubMed ID: 18346464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
    J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Guo L; Fang L; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites.
    Han S; Roman J
    Int J Cancer; 2005 Sep; 116(4):536-46. PubMed ID: 15825163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
    Fu R; Wang X; Hu Y; Du H; Dong B; Ao S; Zhang L; Sun Z; Zhang L; Lv G; Ji J
    Int J Oncol; 2019 May; 54(5):1545-1554. PubMed ID: 30864686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells.
    Zhou Y; Tang Q; Zhao S; Zhang F; Li L; Wu W; Wang Z; Hann S
    Tumour Biol; 2014 Aug; 35(8):8169-78. PubMed ID: 24845028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
    Fan Y; Wang Y; Wang K
    Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Hahn SS; Tang Q; Zheng F; Zhao S; Wu J; Chen J
    Cell Signal; 2014 Mar; 26(3):639-47. PubMed ID: 24361375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-κB potentiates tumor growth by suppressing a novel target LPTS.
    Liu D; Miao H; Zhao Y; Kang X; Shang S; Xiang W; Shi R; Hou A; Wang R; Zhao K; Liu Y; Ma Y; Luo H; Miao H; He F
    Cell Commun Signal; 2017 Oct; 15(1):39. PubMed ID: 29017500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines.
    Yin P; Zhao C; Li Z; Mei C; Yao W; Liu Y; Li N; Qi J; Wang L; Shi Y; Qiu S; Fan J; Zha X
    Cell Signal; 2012 Jun; 24(6):1229-40. PubMed ID: 22360859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase /protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line.
    Li J; Wu X; Gong J; Yang J; Leng J; Chen Q; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):656-63. PubMed ID: 23765166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathways.
    Prijatelj M; Celhar T; Gobec M; Mlinaric-Rascan I
    J Pharm Pharmacol; 2012 Aug; 64(8):1090-8. PubMed ID: 22775212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.